U.S. market Closed. Opens in 2 days 4 hours 58 minutes

NPCE | NeuroPace, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue65.42M45.52M45.18M41.14M36.97M
Cost of Revenue17.30M13.03M11.75M10.87M10.51M
Gross Profit48.12M32.49M33.44M30.27M26.46M
Operating Expenses75.30M73.29M57.17M43.32M48.49M
Selling, General & Admin54.52M51.34M38.96M27.63M30.20M
Research & Development20.78M21.95M18.21M15.70M18.29M
Other Operating Expenses-315.00K-337.00K-5.38M218.00K1.28M
Operating Income-27.17M-40.79M-23.74M-13.05M-22.03M
Other Expenses / Income-5.78M-6.29M-12.34M-11.23M-7.94M
Before Tax Income-32.96M-47.08M-36.08M-24.28M-29.97M
Income Tax Expenses1.44M6.29M2.03M11.70M10.77M
Net Income-32.96M-53.37M-38.11M-35.98M-40.74M
Interest Expenses8.52M7.53M7.41M11.49M9.48M
Basic Shares Outstanding25.85M24.59M24.45M23.83M23.83M
Diluted Shares Outstanding25.85M24.59M24.45M23.83M23.83M
EBITDA-25.57M-39.55M-28.37M-12.48M-20.07M
EBITDA Margin-39.08%-86.89%-62.80%-30.34%-54.28%
EBIT-23.00M-39.55M-28.67M-12.79M-20.49M
EBIT Margin-35.16%-86.89%-63.45%-31.10%-55.41%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙